Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H; Itraconazole Research Group of Germany. Glasmacher A, et al. Among authors: junghanss c. J Antimicrob Chemother. 2006 Feb;57(2):317-25. doi: 10.1093/jac/dki440. Epub 2005 Dec 8. J Antimicrob Chemother. 2006. PMID: 16339606 Clinical Trial.
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Mahlknecht U, Ho A, Schaich M, Kramer M, Kaufmann M, Leimer L, Schwerdtfeger R, Conradi R, Dölken G, Klenner A, Hänel M, Herbst R, Junghanss C, Ehninger G; Study Alliance Leukemia. Wandt H, et al. Among authors: junghanss c. Lancet. 2012 Oct 13;380(9850):1309-16. doi: 10.1016/S0140-6736(12)60689-8. Epub 2012 Aug 8. Lancet. 2012. PMID: 22877506 Clinical Trial.
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO); Böhme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R, Hebart H, Heinz W, Junghanss C, Karthaus M, Krüger W, Krug U, Kubin T, Penack O, Reichert D, Reuter S, Silling G, Südhoff T, Ullmann AJ, Maschmeyer G. Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), et al. Among authors: junghanss c. Ann Hematol. 2009 Feb;88(2):97-110. doi: 10.1007/s00277-008-0622-5. Epub 2008 Oct 14. Ann Hematol. 2009. PMID: 18853161 Review.
Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Böhme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, Heussel G, Heussel CP, Junghanss C, Kern WK, Kubin T, Maschmeyer G, Sezer O, Silling G, Südhoff T, Szelényi Dagger H, Ullmann AJ; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Böhme A, et al. Among authors: junghanss c. Ann Hematol. 2003 Oct;82 Suppl 2:S133-40. doi: 10.1007/s00277-003-0767-1. Epub 2003 Sep 9. Ann Hematol. 2003. PMID: 13680170
Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Buchheidt D, Böhme A, Cornely OA, Fätkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern WV, Schiel X, Sezer O, Südhoff T, Szelényi H; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Buchheidt D, et al. Among authors: junghanss c. Ann Hematol. 2003 Oct;82 Suppl 2:S127-32. doi: 10.1007/s00277-003-0766-2. Epub 2003 Sep 9. Ann Hematol. 2003. PMID: 13680171
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)].
Böhme A, Ruhnke M, Karthaus M, Einsele H, Guth S, Heussel G, Heussel CP, Junghanss C, Kern WV, Kubin T, Sezer O, Silling G, Südhoff T, Szelényi H, Ullmann AJ; Arbeitsgemeinschaft Infektionen in der Hämatolgie und Onkologie der Deutschen Gesellschaft für Hämatology und Onkologie (Working Party on Infections in Hematology and Oncology of the German Society for Hematology and Oncology). Böhme A, et al. Among authors: junghanss c. Dtsch Med Wochenschr. 2001 Dec 14;126(50):1440-7. doi: 10.1055/s-2001-18975. Dtsch Med Wochenschr. 2001. PMID: 11743682 German. No abstract available.
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.
Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C, Peter N, Dölken G, Becker C, Heyn S, Kliem C, Lange T, Krahl R, Pönisch W, Fricke HJ, Sayer HG, Al-Ali H, Kamprad F, Niederwieser D; East German Study Group Hematology and Oncology (OSHO). Basara N, et al. Among authors: junghanss c. Leukemia. 2009 Apr;23(4):635-40. doi: 10.1038/leu.2008.352. Epub 2009 Jan 8. Leukemia. 2009. PMID: 19151786 Clinical Trial.
[Documented infections during neutropenia--therapeutic and diagnostic recommendations. Study Group of Infections in Hematology and Oncology--Expert Group of the German Society for Hematology and Oncology].
Buchheidt D, Böhme A, Cornely O, Fätkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern WV, Schiel X, Sezer O, Südhoff T, Szelenyi H; Study Group of Infections in Hematology and Oncology. Expert Group of the German Society for Hematology and Oncology. Buchheidt D, et al. Among authors: junghanss c. Dtsch Med Wochenschr. 2001 Sep 28;126(39):1085-90. doi: 10.1055/s-2001-17490. Dtsch Med Wochenschr. 2001. PMID: 11602917 Review. German. No abstract available.
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Heinicke T, Krahl R, Kahl C, Cross M, Scholl S, Wolf HH, Hähling D, Hegenbart U, Peter N, Schulze A, Florschütz A, Schmidt V, Reifenrath K, Zojer N, Junghanss C, Sayer HG, Maschmeyer G, Späth C, Hochhaus A, Fischer T, Al-Ali HK, Niederwieser D. Heinicke T, et al. Among authors: junghanss c. Ann Hematol. 2021 Sep;100(9):2387-2398. doi: 10.1007/s00277-021-04565-1. Epub 2021 Jul 7. Ann Hematol. 2021. PMID: 34232360 Free PMC article. Clinical Trial.
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Heinicke T, Krahl R, Kahl C, Cross M, Scholl S, Wolf HH, Hähling D, Hegenbart U, Peter N, Schulze A, Florschütz A, Schmidt V, Reifenrath K, Zojer N, Junghanss C, Sayer HG, Maschmeyer G, Späth C, Hochhaus A, Fischer T, Al-Ali HK, Niederwieser D. Heinicke T, et al. Among authors: junghanss c. Ann Hematol. 2021 Nov;100(11):2877-2878. doi: 10.1007/s00277-021-04638-1. Ann Hematol. 2021. PMID: 34529106 Free PMC article. No abstract available.
200 results